Literature DB >> 20842756

Semi-parametric time-domain quantification of HR-MAS data from prostate tissue.

Helene Ratiney1, Mark J Albers, Herald Rabeson, John Kurhanewicz.   

Abstract

High Resolution--Magic Angle Spinning (HR-MAS) spectroscopy provides rich biochemical profiles that require accurate quantification to permit biomarker identification and to understand the underlying pathological mechanisms. Meanwhile, quantification of HR-MAS data from prostate tissue samples is challenging due to significant overlap between the resonant peaks, the presence of short T₂* metabolites such as citrate or polyamines (T₂ from 25 to 100 msec) and macromolecules, and variations in chemical shifts and T₂*s within a metabolite's spin systems. Since existing methods do not address these challenges completely, a new quantification method was developed and optimized for HR-MAS data acquired with an ultra short T(E) and over 30,000 data points. The proposed method, named HR-QUEST (High Resolution--QUEST), iteratively employs the QUEST time-domain semi-parametric strategy with a new model function that incorporates prior knowledge from whole and subdivided metabolite signals. With these features, HR-QUEST is able to independently fit the chemical shifts and T₂*s of a metabolite's spin systems, a necessity for HR-MAS data. By using the iterative fitting approach, it is able to account for significant contributions from macromolecules and to handle shorter T₂ metabolites, such as citrate and polyamines. After subdividing the necessary metabolite basis signals, the root mean square (RMS) of the residual was reduced by 52% for measured HR-MAS data from prostate tissue. Monte Carlo studies on simulated spectra with varied macromolecular contributions showed that the iterative fitting approach (6 iterations) coupled with inclusion of long T₂ macromolecule components in the basis set improve the quality of the fit, as assessed by the reduction of the RMS of the residual and of the RMS error of the metabolite signal estimate, by 27% and 71% respectively. With this optimized configuration, HR-QUEST was applied to measured HR-MAS prostate data and reliably quantified 16 metabolites and reference signals with estimated Cramér Rao Bounds ≤5%.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20842756      PMCID: PMC3033733          DOI: 10.1002/nbm.1541

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  39 in total

1.  Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain.

Authors:  J Pfeuffer; I Tkác; S W Provencher; R Gruetter
Journal:  J Magn Reson       Date:  1999-11       Impact factor: 2.229

2.  Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T.

Authors:  L L Cheng; C Wu; M R Smith; R G Gonzalez
Journal:  FEBS Lett       Date:  2001-04-06       Impact factor: 4.124

Review 3.  MR spectroscopy quantitation: a review of time-domain methods.

Authors:  L Vanhamme; T Sundin; P V Hecke; S V Huffel
Journal:  NMR Biomed       Date:  2001-06       Impact factor: 4.044

4.  Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging.

Authors:  U G Mueller-Lisse; M G Swanson; D B Vigneron; H Hricak; A Bessette; R G Males; P J Wood; S Noworolski; S J Nelson; I Barken; P R Carroll; J Kurhanewicz
Journal:  Magn Reson Med       Date:  2001-07       Impact factor: 4.668

5.  An algorithm for the automated quantitation of metabolites in in vitro NMR signals.

Authors:  Greg Reynolds; Martin Wilson; Andrew Peet; Theodoros N Arvanitis
Journal:  Magn Reson Med       Date:  2006-12       Impact factor: 4.668

6.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Authors: 
Journal:  J Magn Reson       Date:  1997-11       Impact factor: 2.229

7.  Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.

Authors:  Mark G Swanson; Andrew S Zektzer; Z Laura Tabatabai; Jeffry Simko; Samson Jarso; Kayvan R Keshari; Lars Schmitt; Peter R Carroll; Katsuto Shinohara; Daniel B Vigneron; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

8.  Methods for metabolic evaluation of prostate cancer cells using proton and (13)C HR-MAS spectroscopy and [3-(13)C] pyruvate as a metabolic substrate.

Authors:  Yakir S Levin; Mark J Albers; Thomas N Butler; Daniel Spielman; Donna M Peehl; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2009-11       Impact factor: 4.668

9.  Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy.

Authors:  Julian L Griffin; Mary Bollard; Jeremy K Nicholson; Kishore Bhakoo
Journal:  NMR Biomed       Date:  2002-10       Impact factor: 4.044

10.  Java-based graphical user interface for the MRUI quantitation package.

Authors:  A Naressi; C Couturier; J M Devos; M Janssen; C Mangeat; R de Beer; D Graveron-Demilly
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.533

View more
  14 in total

1.  Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.

Authors:  Roopa Thapar; Mark A Titus
Journal:  Curr Metabolomics       Date:  2014-04

2.  Identifying malignant transformations in recurrent low grade gliomas using high resolution magic angle spinning spectroscopy.

Authors:  Alexandra Constantin; Adam Elkhaled; Llewellyn Jalbert; Radhika Srinivasan; Soonmee Cha; Susan M Chang; Ruzena Bajcsy; Sarah J Nelson
Journal:  Artif Intell Med       Date:  2012-03-03       Impact factor: 5.326

3.  A combined chemometric and quantitative NMR analysis of HIV/AIDS serum discloses metabolic alterations associated with disease status.

Authors:  Tracy R McKnight; Hikari A I Yoshihara; Lungile J Sitole; Jeffery N Martin; Francois Steffens; Debra Meyer
Journal:  Mol Biosyst       Date:  2014-11

4.  Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma.

Authors:  Tracy R McKnight; Kenneth J Smith; Philip W Chu; King S Chiu; Colleen P Cloyd; Susan M Chang; Joanna J Phillips; Mitchel S Berger
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

5.  Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas.

Authors:  Adam Elkhaled; Llewellyn E Jalbert; Joanna J Phillips; Hikari A I Yoshihara; Rupa Parvataneni; Radhika Srinivasan; Gabriela Bourne; Mitchel S Berger; Susan M Chang; Soonmee Cha; Sarah J Nelson
Journal:  Sci Transl Med       Date:  2012-01-11       Impact factor: 17.956

Review 6.  A decade in prostate cancer: from NMR to metabolomics.

Authors:  Elita M DeFeo; Chin-Lee Wu; W Scott McDougal; Leo L Cheng
Journal:  Nat Rev Urol       Date:  2011-05-17       Impact factor: 14.432

Review 7.  High-resolution magic angle spinning 1H MRS in prostate cancer.

Authors:  Emily A Decelle; Leo L Cheng
Journal:  NMR Biomed       Date:  2013-03-26       Impact factor: 4.044

Review 8.  The role of metabolic imaging in radiation therapy of prostate cancer.

Authors:  V Y Zhang; A Westphalen; L Delos Santos; Z L Tabatabai; K Shinohara; D B Vigneron; J Kurhanewicz
Journal:  NMR Biomed       Date:  2013-08-12       Impact factor: 4.044

9.  Characterization of metabolites in infiltrating gliomas using ex vivo ¹H high-resolution magic angle spinning spectroscopy.

Authors:  Adam Elkhaled; Llewellyn Jalbert; Alexandra Constantin; Hikari A I Yoshihara; Joanna J Phillips; Annette M Molinaro; Susan M Chang; Sarah J Nelson
Journal:  NMR Biomed       Date:  2014-03-05       Impact factor: 4.044

10.  Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate.

Authors:  Meer Basharat; Maysam Jafar; Nandita M deSouza; Geoffrey S Payne
Journal:  NMR Biomed       Date:  2014-02-12       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.